CVS Group (LON:CVSG) Insider Buys £30,475 in Stock

CVS Group plc (LON:CVSG) insider David Wilton purchased 2,500 shares of the company’s stock in a transaction on Tuesday, December 2nd. The shares were purchased at an average cost of GBX 1,219 per share, with a total value of £30,475.

CVS Group Price Performance

Shares of CVS Group stock opened at GBX 1,218 on Wednesday. The firm has a market capitalization of £872.04 million, a PE ratio of 16.55, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. CVS Group plc has a 12 month low of GBX 800 and a 12 month high of GBX 1,648. The business’s 50-day moving average price is GBX 1,265.93 and its 200-day moving average price is GBX 1,249.18.

CVS Group (LON:CVSG) last released its earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. Sell-side analysts forecast that CVS Group plc will post 93.9393939 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CVSG. Jefferies Financial Group raised their target price on shares of CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada upped their price target on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the stock an “outperform” rating in a research note on Tuesday, October 21st. Peel Hunt reiterated a “buy” rating and issued a GBX 1,600 target price on shares of CVS Group in a research note on Tuesday, November 18th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the company a “buy” rating in a research report on Tuesday, October 21st. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research report on Tuesday, November 18th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of GBX 1,724.

CVS Group Company Profile

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.